These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 3868028)
1. Comparison of C-terminal and N-terminal PTH in secondary hyperparathyroidism in renal failure. Hortling L; Puutula-Räsänen L; Fyhrquist F Scand J Urol Nephrol Suppl; 1985; 90():51-4. PubMed ID: 3868028 [TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
3. [Radioimmunologic determination of circulating parathyroid hormone in patients with primary and secondary hyperparathyroidism]. Lo Giudice C; Cascone C; Manente P; Gasparoni P; De Luca M; Rota G; Conte N Minerva Med; 1982 Dec; 73(48):3425-8. PubMed ID: 7177469 [TBL] [Abstract][Full Text] [Related]
4. Secondary hyperparathyroidism in patients on maintenance hemodialysis. Hida M Tokai J Exp Clin Med; 1982 Nov; 7(6):665-70. PubMed ID: 7184198 [TBL] [Abstract][Full Text] [Related]
5. The influence of parathyroid hormone and its fragments on results from midregion and C-terminal specific radioimmunoassays. Kübler N; Krause U; Wagner PK; Beyer J; Rothmund M Exp Clin Endocrinol; 1987 Mar; 89(1):61-9. PubMed ID: 3595732 [TBL] [Abstract][Full Text] [Related]
6. Use of C-terminal parathyroid assays in a large metropolitan hospital. Lum G Ann Clin Lab Sci; 1985; 15(1):55-60. PubMed ID: 3970518 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the molecular forms of immunoreactive parathyroid hormone in primary hyperparathyroidism and in hyperparathyroidism due to renal failure. Gautvik KM; Gautvik VT; Halvorsen JF Scand J Clin Lab Invest; 1983 Nov; 43(7):553-64. PubMed ID: 6658372 [TBL] [Abstract][Full Text] [Related]
8. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure. Zanella MT; Silva MC; Peres RB; Ferreira SR; Draibe SA; Vieira JG Braz J Med Biol Res; 1990; 23(3-4):235-43. PubMed ID: 2094538 [TBL] [Abstract][Full Text] [Related]
9. [Relation between serum levels of C-terminal fragment, beta 2 microglobulin and creatinine in patients with chronic nephropathies at different stages of the disease]. Kowalski D; Starzyk J; Kowalska K Wiad Lek; 1989 Oct 1-Nov 1; 42(19-21):1038-43. PubMed ID: 2700400 [TBL] [Abstract][Full Text] [Related]
10. Effect of one haemodialysis treatment on the plasma concentrations of intact parathyroid hormone and ionised calcium: usefulness of end-dialysis values in evaluating the suppressibility of hyperparathyroidism. Pietilä K; Mustonen J; Mörsky P; Seppälä E; Pasternack A; Koivula T Nephrol Dial Transplant; 1989; 4(2):115-8. PubMed ID: 2496352 [TBL] [Abstract][Full Text] [Related]
11. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism. Kaczirek K; Prager G; Riss P; Wunderer G; Asari R; Scheuba C; Bieglmayer C; Niederle B Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888 [TBL] [Abstract][Full Text] [Related]
12. [Intact whole bioactive parathormone: problems arising from comparing different methods]. Marangella M; Migliardi M; Dutto F; Mengozzi G; Marranca D; Bagnis C; Berutti S; Gallone G; Aimo G; Ramello A; Fonzo D G Ital Nefrol; 2002; 19(4):467-75. PubMed ID: 12369051 [TBL] [Abstract][Full Text] [Related]
13. Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study. Melamed ML; Eustace JA; Plantinga LC; Jaar BG; Fink NE; Parekh RS; Coresh J; Yang Z; Cantor T; Powe NR Nephrol Dial Transplant; 2008 May; 23(5):1650-8. PubMed ID: 18065788 [TBL] [Abstract][Full Text] [Related]
14. Normal responsiveness of serum parathyroid hormone to beta-adrenergic blockade in patients with secondary hyperparathyroidism. Kukreja SC; Williams GA; Vora NM; Hargis GK Horm Metab Res; 1981 Apr; 13(4):233-5. PubMed ID: 6113198 [TBL] [Abstract][Full Text] [Related]
15. Hyperparathyroidism, glucose tolerance and platelet intracellular free calcium in chronic renal failure. Lu KC; Shieh SD; Lin SH; Chyr SH; Lin YF; Diang LK; Li BL; Sheu WH; Ding YA Q J Med; 1994 Jun; 87(6):359-65. PubMed ID: 8041868 [TBL] [Abstract][Full Text] [Related]
16. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery. Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835 [TBL] [Abstract][Full Text] [Related]
17. [Effect of calcium on N-terminal truncation of PTH in human parathyroid cells]. Kawata T; Imanishi Y; Kobayashi K; Tahara H; Ishimura E; Inaba M; Nishizawa Y; Takemoto Y; Onoda N; Okuno S; Ishikawa T Clin Calcium; 2005 Sep; 15 Suppl 1():98-100; discussion 100-1. PubMed ID: 16279017 [TBL] [Abstract][Full Text] [Related]
18. [Comparative study of the diagnostic contribution of C-terminal and medio-regional determination of parathyroid hormone in man]. Demulder A; Michiels N; Brauman H Pathol Biol (Paris); 1987 Feb; 35(2):145-51. PubMed ID: 3550622 [TBL] [Abstract][Full Text] [Related]
19. Homeostasis and action of parathyroid hormone in normal man and patients with mild renal failure. Massry SG; Llach F; Singer FR; Kurokawa K; Coburn JW Proc Eur Dial Transplant Assoc; 1975; 11():451-6. PubMed ID: 812084 [TBL] [Abstract][Full Text] [Related]
20. Secondary hyperparathyroidism in patients on maintenance hemodialysis: study of the N and C-terminal parathyroid hormones. Hida M; Shimbo T; Nakamura K; Wakabayashi T; Saitoh H; Satoh T Tokai J Exp Clin Med; 1983 Jul; 8(3):225-8. PubMed ID: 6670108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]